Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples